Article
Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jan 2005
Mooney Laverne A, Madsen Ann M, Tang Deliang, Orjuela Manuela A, Tsai Wei-Yann, Garduno Elizabeth R, Perera Frederica P
Abstract excerpt
BACKGROUND: Elevated benzo(a)pyrene [B(a)P]-DNA adducts have been associated with 3-fold increased risk of lung cancer in current smokers. We assessed the chemopreventive effects of antioxidant supplementation using B(a)P-DNA adducts in leukocytes as an intermediate cancer risk marker. METHODS: Subjects were randomized to a double-blinded placebo-controlled clinical trial of antioxidant vitamin supplementation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
